InformationONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.TargetsBTK 23.9 nMIn vitroIn TMD-8 cells, ONO-4059 inhibits cell growth
InformationONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.TargetsBTK 23.9 nMIn vitroIn TMD-8 cells, ONO-4059 inhibits cell growth
InformationONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.TargetsBTK 23.9 nMIn vitroIn TMD-8 cells, ONO-4059 inhibits cell growth
InformationONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.TargetsBTK 23.9 nMIn vitroIn TMD-8 cells, ONO-4059 inhibits cell growth
InformationONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.TargetsBTK 23.9 nMIn vitroIn TMD-8 cells, ONO-4059 inhibits cell growth
InformationONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.TargetsBTK 23.9 nMIn vitroIn TMD-8 cells, ONO-4059 inhibits cell growth
InformationONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.TargetsBTK 23.9 nMIn vitroIn TMD-8 cells, ONO-4059 inhibits cell growth
InformationONO-4059 analogue ONO-4059 analogue (ONO-WG-307) is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.TargetsBTK 23.9 nMIn vitroIn TMD-8 cells, ONO-4059 inhibits cell growth